Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03131206
Title A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

thyroid gland cancer

lung non-small cell carcinoma

Therapies

Alectinib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, Irvine Irvine California 92697-7600 United States Details
Beth Israel Deaconess Medical Center Boston Massachusetts 02115 United States Details
Brigham and Women's Hospital Boston Massachusetts 02115 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field